Abstract
Apoptosis, or programmed cell death, represents in cell biology a functional program as important as cell growth or differentiation. Programmed cell death is of basic importance for the development of multicellular organisms and its basic mechanisms are conserved during the evolution of metazoa. Mammalian cells exhibit several different apoptotic pathways that converge to a common endpoint. Each pathway is triggered by a different stimulus: growth factor default, irradiation, induction of the p53 oncosuppressor protein, glucocorticoid hormones (in lymphocytes), ligand binding to Fas/APO (CD95), or tumor necrosis factor receptor (TNF-R), perforin secreted by cytotoxic T cells (reviewed by Hale et al. [1]). As opposed to necrosis, apoptosis is a “clean” process: as the cell shrinks, the cell membrane turns into the “apoptotic shell,” the nucleus is condensed and reduced in volume, and eventually the cell disappears from the tissue, due to phagocytosis by neighboring cells or professional phagocytes, such as macrophages.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hale, A. J., Smith, C. A., Sutherland, L. C., Stoneman, V. E., Longthorne, V., Culhane, A. C., and Williams, G. T. (1996) Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236,1-26.
Vaux, D. L. and Strasser, A. (1996) The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93, 2239–2244.
Vaux, D. L., Weissman, I. L., and Kim, S. K. (1992) Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258, 1955–1957.
Ellis, R. E., Yuan, J. Y., and Horvitz, H. R. (1991) Mechanisms of functions of cell death. Ann. Rev. Cell. Biol. 7, 663–698.
Yuan, J., Shahan, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R. (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75, 641–652.
Miura, M., Zhu, H., Rotello, R., Hartwiegh, E. A., and Yuan, J. (1993) Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653–660.
Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J. Biol. Chem. 269, 30,761–30,764.
Munday, N. A., Villancourt, J. P., Ali, A., et al. (1995) Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII members of the ICE/CED-3 family of cysteine proteases. J. Biol. Chem. 270, 15,870–15,876.
Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346–347.
Itoh, N., and Nagata, S. (1993) A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268, 10,932–10,937.
Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O’Rourke, K., Kischkel, F. C., et al. (1996) FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961–4965.
Chinnaiyan, A. M., O’Rourke, K., Yu, G. L., Lyons, R. H., Garg, M., Duan, D. R., Xing, L., Gentz, R., Ni, T., and Dixit, V. M. (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990–992.
Nagata, S. (1997) Apoptosis by death factor. Cell 88, 355–365.
Fisher, G. H., Rosenberg, F. J, Straus, S. E., Dole, J. K., Middleton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J., and Puck, J. M. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935–946.
Tanaka, M., Suda, T., Haze, K., et al. (1996) Fas ligand in human serum. Nat. Med. 2, 317–322.
Bottino, C., Tambussi, G., Ferrini, S., Ciccone, E., Varese, P., Mingari, M. C., Moretta, L., and Moretta, A. (1988) Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor. J. Exp. Med. 168, 491–505.
Cohen, J. J. (1993) Apoptosis. Immunol. Today 14, 126–130.
Curnow, S. J., Glennie, M. J., and Stevenson, G. T. (1993) The role of apoptosis in antibody-dependent cellular cytotoxicity. Cancer Immunol. Immunother. 36, 149–155.
Cleary, M. L., Smith, S. D., and Sklar, J. (1986) Cloning and structural analysis of cDNAs for bcl-2 and hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47, 19–28.
Magrath, I. (1990) The pathogenesis of Burkitt’s lymphoma. Adv. Cancer Res. 55, 133–270.
Okan, I., Wang, Y., Chen, F., Hu, L., Imreh, S., Klein, G., and Wiman, K. G. (1995) The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene 11, 1027–1031.
Silins, S. L. and Sculley, T. B. (1995) Burkitt’s lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4. Int. J. Cancer 60, 65–72.
Yonish-Rouach, E., Grunwald, D., et al. (1993) p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13, 1415–1423.
Matulonis, U., Salgia, R., Okuda, K., Druher, B., Griffin, J. D. (1993) Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent cell line. Exp. Hematal. 21, 1460–1466.
Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., and Mountz, J. D. (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759–1762.
Strasser. A., Harris, A. W., and Cory, S. (1991) bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67, 889–899.
Rajapaksa, R., Ginzton, N., Rott, L. S., and Greenberg, P. L. (1996) Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood 88, 4275–4287.
Yoshida, Y. (1993) Hypothesis: apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplastic syndrome. Leukemia 7, 144–146.
Cotter, T. G., Glynn, J. M., Echeverri, F., and Green, D. R. (1992) The induction of apoptosis by chemoterapeutic agents occurs in all phases of the cell cycle. Anticancer Res. 12, 773–779.
Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456–1462.
Groux, H., Torpier, G., Monte, D., Mouton, Y., Capron, A., and Amisen, J. C. (1992) Activation-induced death by apoptosis in CD4+T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175, 331–340.
Magnelli, L., Cinelli, M., and Chiarugi, V. (1995) Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect TS-p53/K562 from apoptosis. Biochem. Biophys. Res. Commun. 215, 641–645.
Magnelli, L., Cinelli, M., and Chiarugi, V. (1993) Apoptosis induction in 32D cells by IL-3 withdrawal is preceded by a drop in the intracellular calcium level. Biochem. Biophys. Res. Commun. 194, 1394–1397.
Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. CellBiol. 119, 493–501.
Darzynkiewicz, Z., Juan, G., Li, X., Gorczyca, W., Murakami, T., and Traganos, F. (1997) Cytometry in cell necrobiology: analisis of apoptosis and accidental cell death necrosis. Cytometry 27, 1–20.
Frankfurt, O. S. (1999) Immunoassay for single-stranded DNA in apoptotic cells. Methods Mol. Biol. 113, 621–631.
Homburg, C. H., de Haas, M., von der Borne, A. E., Verhoeven, A. J., Reutelingsperger, C. P., and Roos, D. (1995) Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 85, 532–540.
D’Mello, S. R., Aglieco, F., Roberts, M. R., Borodezt, K., and Haycock, J. W. (1998) A DEVD-inhibited caspase other than CPP32 is involved in the committment of cerebellar granule neurons to apoptosis induced by K+deprivation. J. Neurochem. 70, 1809–1818.
Kumar, S. and Colussi, P. A. (1999) Prodomains-adaptors-oligomerization: the pursuit of caspase activation in apoptosis. Trends Biochem. Sci. 24, 1–4.
Thornberry, N. and Lazebnik, Y. (1998) Caspases: enemies within. Science 281, 1312–1316.
Smith, M. J., and Trapani, J. A. (1995) Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol. Today 16, 202–206.
Hahne, M., Peitsch, M. C., Irmler, M., et al. (1995) Characterization of the nonfunctional Fas ligand of gld mice. Int. Immunol. 7, 1381–1386.
Hahne, M., Rimoldi, D., Scrhoter, M., et al. (1996) Melanoma cell expression of Fas (APO-1/CD95) ligand: implications for tumor immune escape. Science 274, 1363–1366.
Thilenius, A. R., Braun, K., and Russell, J. H. (1997) Agonist antibody and Fas ligand mediate different sensitiviy to death in the signalling pathway of Fas and cytoplasmic mutants. Eur. J. Immunol. 27, 1108-1114.
Hannun, Y. A. and Obeid, L. M. (1995) Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20, 73–77.
Hannun, Y. A. (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855–1959.
Pepper, J. S., Montesano, R., Mandriota, S. J., Orci, L., and Vassalli, J. D. (1996) Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49, 138–162.ar Fla
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Chiarugi, V., Cinelli, M., Magnelli, L., Dello Sbarba, P. (2001). Apoptosis. In: Faguet, G.B. (eds) Hematologic Malignancies. Methods in Molecular Medicine™, vol 55. Humana Press. https://doi.org/10.1385/1-59259-074-8:323
Download citation
DOI: https://doi.org/10.1385/1-59259-074-8:323
Publisher Name: Humana Press
Print ISBN: 978-0-89603-543-0
Online ISBN: 978-1-59259-074-2
eBook Packages: Springer Protocols